PMS25 COST-EFFECTIVENESS OF RITUXIMAB (MABTHERA) COMPARED WITH TNF INHIBITORS FOR THE TREATMENT OF RHEUMATOID ARTHRITIS (RA) IN POLAND
Nov 1, 2008, 00:00 AM
10.1016/S1098-3015(10)66794-0
https://www.valueinhealthjournal.com/article/S1098-3015(10)66794-0/fulltext
Section Title :
Section Order :
629
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)66794-0&doi=10.1016/S1098-3015(10)66794-0